文献速递白血病

更正:奥英妥珠单抗治疗儿童复发/难治性急性淋巴细胞白血病

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2019-01-01

本文是对《奥英妥珠单抗治疗儿童复发/难治性急性淋巴细胞白血病》一文的更正,致谢了参与数据收集的研究协调员和儿科肿瘤中心医生,列出了多家医院及人员名单。

要点

  • 本文为更正声明,致谢参与数据收集的研究协调员和医生。
  • 列出了多家儿科肿瘤中心及贡献者名单。
  • 未涉及研究数据、结果或临床推荐。

核心结论

  • 本文是对原文的更正,致谢参与数据收集的研究协调员和医生。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwarkar and Jayashree Motwani, Birmingham Women's and Children's Hospital, UK; Kelly Malone, Children's Hospital of Colorado, USA; Mylene Bassal, Children's Hospital of Eastern Ontario, Canada; Yoav Messinger and Joanna Perkins, Children's Hospital of Minnesota, USA; Van Huynh, Children's Hospital of Orange County, USA; Richard Ho, Children's Hospital at Vanderbilt, USA; Joanne Chuah and Jessa Morales, Children's Hospital at Westmead, Australia; Donald Wells, Dell Children's Hospital, USA; Nicolas Boissel, Hospital Saint-Louis, France; Tannie Huang, Kaiser Permanente, USA; Stacey Marjerrison, McMaster Children's Hospital, Canada; William Carroll and Joanna Pierro, New York University Langone Medical Center, USA; Ajay Vora, Sheffield Children's Hospital, UK; Donna Lancaster, The Royal Marsden Hospital, UK; Lucie Šrámková, University Hospital Motol, Czech Republic; Chatchawin Assanasen, University of Texas Health Science Center, San Antonio, USA; Rupert Handgretinger, University of Tübingen, Germany.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bhojwani D, Sposto R, Shah NN, et al. Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019. PMID: 30842605. doi:10.1038/s41375-019-0426-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。